The Problem
Medical research teams often compare biomarkers such as CRP, troponin, HbA1c, cytokines, enzyme activity, or imaging-derived measurements across patient groups. The average value matters, but it is not enough. A biomarker with wide spread can weaken subgroup comparisons, inflate uncertainty, and make it harder to tell whether a pattern is biological, analytical, or caused by inconsistent collection.
Standard deviation gives researchers a first check on that spread. It helps decide whether pilot data are stable enough for a larger study, whether one assay batch is behaving differently, whether a reference interval may need partitioning, and whether a reported mean should be interpreted cautiously.
Why Standard Deviation Helps
For continuous biomarkers, the sample standard deviation estimates how far individual measurements typically fall from the study mean. In practice, that spread can combine biological variation, pre-analytical variation, instrument precision, batch effects, and data-entry problems. Reviewing SD early helps the team separate a real patient signal from preventable noise.
Sample Standard Deviation for Biomarker Values
Pair SD with Relative Spread
SD is also the bridge between raw patient-level variability and decision statistics. Use it with the standard error calculator, the confidence intervals guide, and the coefficient of variation article when reporting a study mean or comparing markers measured on different scales.
Worked Example
A translational research group measures a blood biomarker in 20 patients from a pilot cohort. The mean appears similar across two processing batches, but the team notices that Batch B has a much wider spread. Before using the values for subgroup discovery, they compare the SD and relative spread.
| Group | Mean Biomarker Level | Standard Deviation | Relative Standard Deviation | Interpretation |
|---|---|---|---|---|
| Batch A | 48 ng/mL | 5.6 ng/mL | 11.7% | Consistent pilot measurements |
| Batch B | 50 ng/mL | 14.2 ng/mL | 28.4% | Similar mean, much wider spread |
| Batch B after review | 49 ng/mL | 7.1 ng/mL | 14.5% | Spread improves after two handling errors are corrected |
What the SD Changed
Decision Criteria
| Observed Pattern | Likely Meaning | Recommended Action |
|---|---|---|
| Mean differs and SD is similar across groups | Group comparison is easier to interpret because dispersion is balanced | Move to effect estimates, confidence intervals, and planned statistical tests |
| Mean is similar but one group has much higher SD | Possible subgroup heterogeneity, batch effect, or inconsistent sample handling | Check processing logs, assay plates, subgroup composition, and outliers before pooling |
| SD is high relative to the clinical difference of interest | The biomarker may be too noisy for the planned decision threshold | Increase sample size, improve measurement protocol, or choose a more stable endpoint |
| Repeated control samples show rising SD over time | Assay precision may be drifting | Review calibration, reagent lots, operator changes, and instrument maintenance |
| Distribution is strongly skewed | The mean and SD may not summarize the data well | Inspect the distribution and consider transformation or robust summaries |
Do Not Use SD as a Clinical Decision Rule by Itself
Research Workflow
Define the measurement unit and analysis population
Calculate SD for the planned analysis set
Compare spread across batches and subgroups
Investigate unusual values before excluding them
Translate variability into reporting precision
- Keep raw units and transformed units separate when reporting SD.
- Document whether SD comes from all participants, controls only, a single subgroup, or repeated quality-control samples.
- Compare SD with the minimum clinically important difference before treating a biomarker as decision-ready.
- Review pre-analytical factors such as collection tube, storage time, freeze-thaw cycles, and assay lot when spread changes suddenly.
Tools & Next Steps
Sample Standard Deviation Calculator
Relative Standard Deviation Calculator
Standard Error Calculator
Confidence Intervals Guide
Further Reading
Sources
References and further authoritative reading used in preparing this article.
- Bioanalytical Method Validation for Biomarkers — FDA
- EP28: Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory — CLSI
- Models to Estimate Biological Variation Components and Interpretation of Serial Results — Clinical Chemistry and Laboratory Medicine